Canada MDL vs MDEL: Device Licensing
Last reviewed:
Determine which Canadian product and establishment licences apply to each device and supply-chain activity.
MDL versus MDEL: licence the product and the activity correctly
A Medical Device Licence (MDL) concerns a Class II, III or IV product and its manufacturer. A Medical Device Establishment Licence (MDEL) concerns specified manufacturing/import/distribution activities. Both are overseen by Health Canada, but they answer different regulatory questions.
Use Health Canada’s MDEL guidance and licensing FAQs to assess the actual activities. “We already have a licence” is insufficient unless it is the right licence for the product and business role.
Activity-based licensing matrix
| Situation | MDL | MDEL assessment |
|---|---|---|
| Class I manufacturer | No product MDL | Generally required, with an exemption where the applicable sole-distribution-through-an-MDEL-holder conditions are met |
| Class II–IV manufacturer selling/importing its own licensed devices | Required for the devices | Manufacturer exemption can apply to its own licensed products |
| Importer/distributor of another manufacturer’s devices | Manufacturer must hold required MDLs for II–IV | Generally requires MDEL unless a specific exemption applies |
| Retail or healthcare-facility activity | Product still needs the applicable legal status | Assess the specific establishment exemption and actual activities |
If an establishment performs several activities, evaluate all of them. A foreign establishment is not automatically exempt merely because it is outside Canada, and an importer cannot assume that the manufacturer’s MDL covers its independent activities.
Evidence for the product licence
Confirm the Canadian risk class and IVD/device rules, legal manufacturer, intended use, model range and application category. Class II–IV manufacturers generally need the relevant ISO 13485 certificate under MDSAP. Reconcile certificate scope and sites with the licence application. Higher classes require more detailed supporting safety/effectiveness information.
Use REP and CESG for covered transactions under the April 1, 2026 requirement. Keep enrolment, dossier and device identifiers aligned, and retain transmission acknowledgments and final licence records. MDEL follows its own application instructions rather than automatically using the MDL route.
Evidence for the establishment licence
Define establishment identity, sites, activities, device classes and relevant manufacturers. Implement documented procedures for distribution records, complaint handling and recalls, with other required procedures appropriate to the activity. The application’s attestations must describe operating controls, not future intentions.
Create a responsibility map linking the legal manufacturer, importer, distributor and service providers. State who receives safety information, evaluates reportability, notifies Health Canada, locates affected units and implements recalls. Outsourcing a task does not eliminate the licence holder’s obligations.
Annual review and change management
For MDEL, track annual licence review before April 1 and the separate invoice/payment requirements. For MDL, track the annual renewal notification before November 1 and applicable right-to-sell fees. Maintain quality certificates and assess licence amendments, activity/site changes and manufacturer changes under the correct process.
Before the first shipment, verify the current product licence where required and the establishment permissions of the actual supply chain. Use the public Health Canada listings as a check, but retain the controlled documents and underlying rationale. Follow the Canada market guide for labeling and wider postmarket requirements. Pure Global can map the licensing responsibilities, prepare applications and help maintain a consistent renewal and change calendar.
Regulatory Update · Sep 10, 2025Health Canada eSTAR Pilot 2025: Streamlining Class III & IV SubmissionsBlog · Aug 24, 2026Medical Device Registration Verification 2026Blog · Aug 17, 2026Coronary Stents: Eight Highest-Tier FilesBlog · Aug 10, 2026Surgical Robots: Eight Markets, Eight Regulatory FilesBlog · Aug 3, 2026ISO 10993-1:2025: One Core, Seven Regulatory SystemsVideo · Jul 28, 2025How to Register a Medical Device in CanadaRegulatory Update · Oct 11, 2026ANMAT Foreign Plant GMP CertificatesRegulatory Update · Oct 1, 2026ANVISA–Hong Kong DH Cooperation MoURegulatory Update · Sep 17, 2026FDA Buffy Coat System GuidanceCase Study · Aug 11, 2026One Balloon-Catheter Line, Two ANVISA RoutesPlan your submission with Pure Global
Plan your device registration, local representation and ongoing compliance with Pure Global.
Frequently asked questions
No. The MDEL concerns establishment activities. Class II–IV devices still require the appropriate manufacturer-held MDLs, and all products must meet their applicable regulatory and labeling requirements.
A Class I manufacturer generally needs an MDEL, but a specific exemption can apply when distribution is solely through an eligible MDEL holder under the regulations. Confirm the complete supply-chain arrangement and exemption conditions.
A manufacturer importing or distributing its own licensed Class II–IV devices can fall within the manufacturer exemption. Activities involving other manufacturers’ devices or additional roles require a separate assessment.
Single Process,
Multiple Markets
When you partner with Pure Global, a single registration process opens doors to multiple countries. Our global subsidiaries make this streamlined path possible.
Let's Talk,
Anywhere You Are.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us